Real-World Clinical Outcomes After Sustained Delivery of the 0.19 mg Fluocinolone Acetonide Implant for Treatment of Diabetic Macular Edema

Real-World Clinical Outcomes After Sustained Delivery of the 0.19 mg Fluocinolone Acetonide Implant for Treatment of Diabetic Macular Edema

From ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum by American Society of Retina Specialists (ASRS)

February 17, 2026 · 12 min

About this episode

Dr. Joseph Coney discusses his study on the clinical outcomes of a specific implant treatment for diabetic macular edema.

On this episode of the JVRD Author’s Forum podcast, retina specialist Dr. Joseph Coney, Managing Partner of Retina Associates of Cleveland, discusses his study, “Real-World Clinical Outcomes After Sustained Delivery of the 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema,” published in JVRD. Host Dr. Timothy Murray speaks with Dr. Coney about his retrospective real-world analysis of patients with chronic, refractory diabetic macular edema treated with t...

People in this episode

Host: Dr. Timothy Murray

Guest: Dr. Joseph Coney

Topics covered

  • diabetic macular edema
  • clinical outcomes
  • retina specialists
  • Fluocinolone Acetonide
  • real-world analysis

Keywords

  • diabetic macular edema
  • Fluocinolone Acetonide
  • clinical outcomes
  • retina specialists
  • real-world analysis

Mentioned in this episode

Organizations: Retina Associates of Cleveland, American Society of Retina Specialists, JVRD

Books & works: Real-World Clinical Outcomes After Sustained Delivery of the 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema

More episodes of ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum

Explore listener stats, chart rankings, contacts and more on the ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum podcast page.